Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection

Immunomodulatory and analgesic effects of dexamethasone are clinically well established, and this synthetic corticosteroid acts as an agonist of glucocorticoid receptors. Early results of the RECOVERY Trial from the United Kingdom and others suggest certain benefits of dexamethasone against COVID-19...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Per Med
Asıl Yazarlar: Vohra, Manik, Sharma, Anu Radha, Satyamoorthy, Kapaettu, Rai, Padmalatha S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Future Medicine Ltd 2021
Konular:
Special Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8186476/
https://ncbi.nlm.nih.gov/pubmed/34086487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pme-2020-0183
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller